Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation.

Goetghebuer, Tessa;Le Chenadec, Jerome;Haelterman, Edwige;Galli, Luisa;Warszawski, Josiane;et.al.
(2012) Clinical infectious diseases : an official publication of the Infectious Diseases Society of America —

Files

No attached file found for this publication.

Details

Authors
  • Goetghebuer, Tessa
    Author
  • Le Chenadec, Jerome
    Author
  • Haelterman, Edwige
    Author
  • Galli, Luisa
    Author
  • Brichard, BénédicteUCLouvain
    Collaborator
  • Warszawski, Josiane
    Author
Show more
Abstract
The clinical benefit of antiretroviral therapy in infants is established. In this cohort collaboration, we compare immunological and virological response to treatment started before or after 3 months of age. Early initiation provides a better short-term response, although evolution after 12 months of age is similar in both groups.

Citations

  • APA
  • Chicago
  • FWB

Goetghebuer, T., Le Chenadec, J., Haelterman, E., Galli, L., Dollfus, C., Thorne, C., Judd, A., Keiser, O., Ramos, J. T., Levy, J., & Warszawski, J. (2012). Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/cir950